BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31755702)

  • 21. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.
    Olaoye OO; Watson PR; Nawar N; Geletu M; Sedighi A; Bukhari S; Raouf YS; Manaswiyoungkul P; Erdogan F; Abdeldayem A; Cabral AD; Hassan MM; Toutah K; Shouksmith AE; Gawel JM; Israelian J; Radu TB; Kachhiyapatel N; de Araujo ED; Christianson DW; Gunning PT
    J Med Chem; 2021 Mar; 64(5):2691-2704. PubMed ID: 33576627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity.
    Gomes ID; Ariyaratne UV; Pflum MKH
    ACS Chem Biol; 2021 Aug; 16(8):1435-1444. PubMed ID: 34314149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-solution structure and oligomerization of human histone deacetylase 6 - an integrative approach.
    Shukla S; Komarek J; Novakova Z; Nedvedova J; Ustinova K; Vankova P; Kadek A; Uetrecht C; Mertens H; Barinka C
    FEBS J; 2023 Feb; 290(3):821-836. PubMed ID: 36062318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
    Ferreira de Freitas R; Harding RJ; Franzoni I; Ravichandran M; Mann MK; Ouyang H; Lautens M; Santhakumar V; Arrowsmith CH; Schapira M
    J Med Chem; 2018 May; 61(10):4517-4527. PubMed ID: 29741882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation.
    Ustinova K; Novakova Z; Saito M; Meleshin M; Mikesova J; Kutil Z; Baranova P; Havlinova B; Schutkowski M; Matthias P; Barinka C
    J Biol Chem; 2020 Feb; 295(9):2614-2628. PubMed ID: 31953325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches.
    Banerjee S; Jana S; Jha T; Ghosh B; Adhikari N
    Comput Biol Chem; 2024 Jun; 110():108051. PubMed ID: 38520883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity.
    Cellupica E; Caprini G; Cordella P; Cukier C; Fossati G; Marchini M; Rocchio I; Sandrone G; Vanoni MA; Vergani B; Źrubek K; Stevenazzi A; Steinkühler C
    J Biol Chem; 2023 Jan; 299(1):102800. PubMed ID: 36528061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.
    Osko JD; Christianson DW
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127023. PubMed ID: 32067866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDAC6 ZnF UBP as the Modifier of Tau Structure and Function.
    Balmik AA; Chidambaram H; Dangi A; Marelli UK; Chinnathambi S
    Biochemistry; 2020 Dec; 59(48):4546-4562. PubMed ID: 33237772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
    Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
    Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.
    Goracci L; Deschamps N; Randazzo GM; Petit C; Dos Santos Passos C; Carrupt PA; Simões-Pires C; Nurisso A
    Sci Rep; 2016 Jul; 6():29086. PubMed ID: 27404291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
    Vögerl K; Ong N; Senger J; Herp D; Schmidtkunz K; Marek M; Müller M; Bartel K; Shaik TB; Porter NJ; Robaa D; Christianson DW; Romier C; Sippl W; Jung M; Bracher F
    J Med Chem; 2019 Feb; 62(3):1138-1166. PubMed ID: 30645113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of High-Content Analysis for Screening HDAC6-Selective Inhibitors.
    Nong Y; Hou Y; Pu Y; Li S; Lan Y
    SLAS Discov; 2021 Jun; 26(5):628-641. PubMed ID: 33783263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
    Li M; Zhuang Y; Shan B
    Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.
    Brush MH; Guardiola A; Connor JH; Yao TP; Shenolikar S
    J Biol Chem; 2004 Feb; 279(9):7685-91. PubMed ID: 14670976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Novel Histone Deacetylase 6-Selective Inhibitors Bearing 3,3,3-Trifluorolactic Amide (TFLAM) Motif as a Zinc Binding Group.
    Kurohara T; Tanaka K; Takahashi D; Ueda S; Yamashita Y; Takada Y; Takeshima H; Yu S; Itoh Y; Hase K; Suzuki T
    Chembiochem; 2021 Nov; 22(22):3158-3163. PubMed ID: 34224197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors.
    Tavares MT; Kozikowski AP; Shen S
    Eur J Med Chem; 2021 Jan; 209():112887. PubMed ID: 33035922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.